financetom
Market
financetom
/
Market
/
Micron Technology, Accenture And 3 Stocks To Watch Heading Into Thursday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Micron Technology, Accenture And 3 Stocks To Watch Heading Into Thursday
Sep 25, 2024 11:10 PM

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Wall Street expects Accenture plc ( ACN ) to report quarterly earnings at $2.77 per share on revenue of $16.39 billion before the opening bell. Accenture ( ACN ) shares rose 1.5% to $342.00 in after-hours trading.

Micron Technology Inc ( MU ) reported better-than-expected fourth-quarter financial results. The company reported fourth-quarter revenue of $7.75 billion, beating the consensus estimate of $7.635 billion. The company reported fourth-quarter adjusted earnings of $1.18 per share, beating analyst estimates of $1.13 per share, according to Benzinga Pro. Micron shares jumped 14.8% to $109.90 in the after-hours trading session.

Analysts expect Jabil Inc ( JBL ). to post quarterly earnings at $2.22 per share on revenue of $6.59 million before the opening bell. Jabil ( JBL ) shares gained 0.1% to $113.58 in the after-hours trading session.

Check out our premarket coverage here

H.B. Fuller Company ( FUL ) reported worse-than-expected financial results for its third quarter and issued weak FY24 earnings guidance. H.B. Fuller ( FUL ) shares dipped 9% to $73.39 in the after-hours trading session.

Analysts expect Costco Wholesale Corporation ( COST ) to post quarterly earnings at $5.08 per share on revenue of $79.97 billion. The company will release earnings after the closing bell. Costco shares gained 0.1% to $908.90 in after-hours trading.

Check This Out:

Top 5 Industrials Stocks That May Collapse In Q3

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall Street retreats on slowdown fears; Dow, small-caps slide
US STOCKS-Wall Street retreats on slowdown fears; Dow, small-caps slide
Aug 1, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * US manufacturing gauge drops to eight-month low * Arm Holdings down after tepid Q2 revenue forecast * Eli Lilly ( LLY ) up as weight-loss drug cut heart failure risk in trial * Moderna ( MRNA ) slumps after...
South African rand firms on Fed rate cut bets
South African rand firms on Fed rate cut bets
Aug 1, 2024
JOHANNESBURG, Aug 1 (Reuters) - South Africa's rand firmed on Thursday as investors bet on a September interest rate cut in the world's biggest economy after dovish comments by the U.S. Federal Reserve on Wednesday. At 1540 GMT, the rand traded at 18.20 against the dollar , about 0.1% stronger than its previous close. The rand traded below the R18.20...
US Equity Indexes, Treasury Yields Dive as Jobless Claims Surge Amid Worsening Manufacturing Activity
US Equity Indexes, Treasury Yields Dive as Jobless Claims Surge Amid Worsening Manufacturing Activity
Aug 1, 2024
12:50 PM EDT, 08/01/2024 (MT Newswires) -- US equity indexes slumped with government bond yields as jobless claims hit the highest in a year while a manufacturing gauge surprisingly sank deeper into contractionary territory. The Nasdaq dropped 1.7% to 17,301.5, with the S&P 500 down 1.1% to 5,461.4 and the Dow Jones Industrial Average 1.2% lower at 40,335.8 after midday...
US STOCKS-Wall St gains on September rate-cut hopes; Meta soars
US STOCKS-Wall St gains on September rate-cut hopes; Meta soars
Aug 1, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * US weekly jobless claims data higher than expected * Arm Holdings down after tepid Q2 revenue forecast * Eli Lilly ( LLY ) up as weight-loss drug cut heart failure risk in trial * Moderna ( MRNA ) slumps...
Copyright 2023-2026 - www.financetom.com All Rights Reserved